23185-Biliary Cancer-NA-22

Biliary Cancer

An open-label randomized trial of the efficacy and safety of zanidatamab with standard-of-care therapy against standard-of-care therapy alone for advanced HER2-positive biliary tract cancer (JZP598-302)

  • Details

ClinicalTrials.gov ID: NCT06282575
Diagnosis Type: NA
USOR Number:

  • Address


,
P:

Search by practice name, trial titles, indicators and specific disease types.